Cargando…

Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients

BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full len...

Descripción completa

Detalles Bibliográficos
Autores principales: Rot, Swetlana, Kaune, Tom, Taubert, Helge, Greither, Thomas, Kotrba, Johanna, Güttler, Antje, Wichmann, Henri, Bilkenroth, Udo, Wienke, Andreas, Al-Nawas, Bilal, Bache, Matthias, Vordermark, Dirk, Wickenhauser, Claudia, Bethmann, Daniel, Eckert, Alexander W., Kappler, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377725/
https://www.ncbi.nlm.nih.gov/pubmed/30770730
http://dx.doi.org/10.1186/s12885-019-5327-8
_version_ 1783395801037275136
author Rot, Swetlana
Kaune, Tom
Taubert, Helge
Greither, Thomas
Kotrba, Johanna
Güttler, Antje
Wichmann, Henri
Bilkenroth, Udo
Wienke, Andreas
Al-Nawas, Bilal
Bache, Matthias
Vordermark, Dirk
Wickenhauser, Claudia
Bethmann, Daniel
Eckert, Alexander W.
Kappler, Matthias
author_facet Rot, Swetlana
Kaune, Tom
Taubert, Helge
Greither, Thomas
Kotrba, Johanna
Güttler, Antje
Wichmann, Henri
Bilkenroth, Udo
Wienke, Andreas
Al-Nawas, Bilal
Bache, Matthias
Vordermark, Dirk
Wickenhauser, Claudia
Bethmann, Daniel
Eckert, Alexander W.
Kappler, Matthias
author_sort Rot, Swetlana
collection PubMed
description BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5FL) in progression and prognosis of several cancers was reported. However, the biological function of three splice variants of LGR5 (LGR5Δ5, LGR5Δ8 and LGR5Δ5–8) has yet to be thoroughly investigated. METHODS: Seventy-eight frozen tumor samples from adult OSCC patients were studied using quantitative real-time TaqMan™ PCR analysis. The mRNA levels of full length LGR5, the splice variant of LGR5 lacking exon 5 (LGR5Δ5), the splice variant of LGR5 lacking exon 8 (LGR5Δ8) and the mRNA level of all known transcript variants together (LGR5all) were quantified and correlated to overall and disease-specific survival of OSCC patients, clinical parameters and the mRNA level of different tumor-associated markers. RESULTS: An elevated level of tumoral LGR5Δ5 mRNA, but not LGR5FL, LGR5Δ8 or LGR5all mRNA was significantly associated with a poor prognosis for the overall and disease-specific survival of OSCC patients (hazard ratio (HR) = 2.0; p = 0.02; 95% CI: 1.1–3.7; HR = 3.2; p = 0.01; 95% CI: 1.3–8.0; multivariable Cox regression), respectively. Additionally, a higher tumoral level of LGR5Δ5 mRNA in primary tumors was associated with the occurrence of regional lymph node metastases in OSCC patients (odds ratio (OR) = 3.1; p = 0.022; 95% CI: 1.2–7.9; binary logistic regression). Furthermore, the mRNA levels of all investigated LGR5 transcript variants were significantly correlated with the mRNA expression of Wnt-target genes and markers of epithelial-to-mesenchymal transition (EMT). CONCLUSION: The mRNA level of the LGR5 splice variant LGR5Δ5 is an independent negative prognostic marker for overall and disease-specific survival and metastasis in OSCC patients. Additionally, we suggest, all LGR5 transcript variants are involved in the EMT process mainly through activating the Wnt-signalling pathway.
format Online
Article
Text
id pubmed-6377725
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63777252019-02-27 Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients Rot, Swetlana Kaune, Tom Taubert, Helge Greither, Thomas Kotrba, Johanna Güttler, Antje Wichmann, Henri Bilkenroth, Udo Wienke, Andreas Al-Nawas, Bilal Bache, Matthias Vordermark, Dirk Wickenhauser, Claudia Bethmann, Daniel Eckert, Alexander W. Kappler, Matthias BMC Cancer Research Article BACKGROUND: The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5FL) in progression and prognosis of several cancers was reported. However, the biological function of three splice variants of LGR5 (LGR5Δ5, LGR5Δ8 and LGR5Δ5–8) has yet to be thoroughly investigated. METHODS: Seventy-eight frozen tumor samples from adult OSCC patients were studied using quantitative real-time TaqMan™ PCR analysis. The mRNA levels of full length LGR5, the splice variant of LGR5 lacking exon 5 (LGR5Δ5), the splice variant of LGR5 lacking exon 8 (LGR5Δ8) and the mRNA level of all known transcript variants together (LGR5all) were quantified and correlated to overall and disease-specific survival of OSCC patients, clinical parameters and the mRNA level of different tumor-associated markers. RESULTS: An elevated level of tumoral LGR5Δ5 mRNA, but not LGR5FL, LGR5Δ8 or LGR5all mRNA was significantly associated with a poor prognosis for the overall and disease-specific survival of OSCC patients (hazard ratio (HR) = 2.0; p = 0.02; 95% CI: 1.1–3.7; HR = 3.2; p = 0.01; 95% CI: 1.3–8.0; multivariable Cox regression), respectively. Additionally, a higher tumoral level of LGR5Δ5 mRNA in primary tumors was associated with the occurrence of regional lymph node metastases in OSCC patients (odds ratio (OR) = 3.1; p = 0.022; 95% CI: 1.2–7.9; binary logistic regression). Furthermore, the mRNA levels of all investigated LGR5 transcript variants were significantly correlated with the mRNA expression of Wnt-target genes and markers of epithelial-to-mesenchymal transition (EMT). CONCLUSION: The mRNA level of the LGR5 splice variant LGR5Δ5 is an independent negative prognostic marker for overall and disease-specific survival and metastasis in OSCC patients. Additionally, we suggest, all LGR5 transcript variants are involved in the EMT process mainly through activating the Wnt-signalling pathway. BioMed Central 2019-02-15 /pmc/articles/PMC6377725/ /pubmed/30770730 http://dx.doi.org/10.1186/s12885-019-5327-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rot, Swetlana
Kaune, Tom
Taubert, Helge
Greither, Thomas
Kotrba, Johanna
Güttler, Antje
Wichmann, Henri
Bilkenroth, Udo
Wienke, Andreas
Al-Nawas, Bilal
Bache, Matthias
Vordermark, Dirk
Wickenhauser, Claudia
Bethmann, Daniel
Eckert, Alexander W.
Kappler, Matthias
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title_full Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title_fullStr Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title_full_unstemmed Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title_short Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients
title_sort prognostic impact of mrna levels of lgr5 transcript variants in oscc patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377725/
https://www.ncbi.nlm.nih.gov/pubmed/30770730
http://dx.doi.org/10.1186/s12885-019-5327-8
work_keys_str_mv AT rotswetlana prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT kaunetom prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT tauberthelge prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT greitherthomas prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT kotrbajohanna prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT guttlerantje prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT wichmannhenri prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT bilkenrothudo prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT wienkeandreas prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT alnawasbilal prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT bachematthias prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT vordermarkdirk prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT wickenhauserclaudia prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT bethmanndaniel prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT eckertalexanderw prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients
AT kapplermatthias prognosticimpactofmrnalevelsoflgr5transcriptvariantsinosccpatients